Literature DB >> 8910949

N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation.

L Verna1, J Whysner, G M Williams.   

Abstract

N-Nitrosodiethylamine (NDEA) is DNA reactive after bioactivation and produces tumors in every animal species tested. Bioactivation is effected by several P450 isozymes including CYP2E1, which is ethanol inducible. Tumor formation in rat liver was proportional to O4-ethyldeoxythymidine formation in DNA, which was generally proportional to NDEA dose. At low doses in the 0.033-1.1 ppm range, the dose-response for esophageal tumor formation was sublinear, possibly due to DNA repair. Although no epidemiological studies have specifically evaluated NDEA, sufficient exposure levels would be expected to cause cancer in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910949     DOI: 10.1016/0163-7258(96)00062-9

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  135 in total

1.  Diethylnitrosamine-induced cirrhosis in Wistar rats: an experimental feasibility study.

Authors:  Silvia Bona; Andrea Janz Moreira; Graziella Ramos Rodrigues; Carlos Thadeu Cerski; Themis Reverbel da Silveira; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  Protoplasma       Date:  2014-11-05       Impact factor: 3.356

2.  Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.

Authors:  Xu-Feng Zhang; Xinping Tan; Gang Zeng; Amalea Misse; Sucha Singh; Youngsoo Kim; James E Klaunig; Satdarshan P S Monga
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

Review 3.  Oral microbiome and oral and gastrointestinal cancer risk.

Authors:  Jiyoung Ahn; Calvin Y Chen; Richard B Hayes
Journal:  Cancer Causes Control       Date:  2012-01-22       Impact factor: 2.506

Review 4.  NF-κB and STAT3 - key players in liver inflammation and cancer.

Authors:  Guobin He; Michael Karin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

5.  Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.

Authors:  Guobin He; Debanjan Dhar; Hayato Nakagawa; Joan Font-Burgada; Hisanobu Ogata; Yuhong Jiang; Shabnam Shalapour; Ekihiro Seki; Shawn E Yost; Kristen Jepsen; Kelly A Frazer; Olivier Harismendy; Maria Hatziapostolou; Dimitrios Iliopoulos; Atsushi Suetsugu; Robert M Hoffman; Ryosuke Tateishi; Kazuhiko Koike; Michael Karin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

6.  Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.

Authors:  A Wree; C D Johnson; J Font-Burgada; A Eguchi; D Povero; M Karin; A E Feldstein
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

7.  Diminished S-adenosylmethionine biosynthesis and its metabolism in a model of hepatocellular carcinoma is recuperated by an adenosine derivative.

Authors:  María Guadalupe Lozano-Rosas; Enrique Chávez; Gabriela Velasco-Loyden; Mariana Domínguez-López; Lidia Martínez-Pérez; Victoria Chagoya De Sánchez
Journal:  Cancer Biol Ther       Date:  2019-09-25       Impact factor: 4.742

8.  Ductular reaction, cytokeratin 7 positivity, and gamma-glutamyl transferase in multistage hepatocarcinogenesis in rats.

Authors:  Andrea Janz Moreira; Graziella Ramos Rodrigues; Silvia Bona; Leila Xavier Sinigaglia Fratta; Giovana Regina Weber; Jaqueline Nascimento Picada; Jorge Luiz Dos Santos; Carlos Thadeu Cerski; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  Protoplasma       Date:  2016-08-15       Impact factor: 3.356

9.  DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats.

Authors:  H-X Yan; H-P Wu; H-L Zhang; C Ashton; C Tong; J Wu; Q-J Qian; H-Y Wang; Q-L Ying
Journal:  Oncogene       Date:  2012-10-15       Impact factor: 9.867

10.  Metalloproteinases 2 and 9 activity during promotion and progression stages of rat liver carcinogenesis.

Authors:  Kelly Silva Furtado; Paulo Wagner Pires; Luis Antonio Justulin; Maria Aparecida Marchesan Rodrigues; Sergio Luis Felisbino; Luis Fernando Barbisan
Journal:  J Mol Histol       Date:  2008-12-04       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.